Cart
sales@molnova.com
(Rac)-Z-Phe-Phe-FMK
CAS No. 108005-94-3
(Rac)-Z-Phe-Phe-FMK( —— )
Catalog No. M35042 CAS No. 108005-94-3
(Rac)-Z-Phe-Phe-FMK (Cathepsin L-IN-2) is a cathepsin L inhibitor that inhibits the tendency of β-amyloid to induce apoptotic changes .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 302 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(Rac)-Z-Phe-Phe-FMK
-
NoteResearch use only, not for human use.
-
Brief Description(Rac)-Z-Phe-Phe-FMK (Cathepsin L-IN-2) is a cathepsin L inhibitor that inhibits the tendency of β-amyloid to induce apoptotic changes .
-
DescriptionCathepsin L-IN-2 (Z-Phe-Phe-FMK) is a potent and irreversible cathepsin L and cathepsin B inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetCysteine Protease
-
RecptorCysteine Protease | Beta Amyloid
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number108005-94-3
-
Formula Weight462.51
-
Molecular FormulaC27H27FN2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 42.5 mg/mL (91.89 mM; Ultrasonic )
-
SMILESO=C(OCC=1C=CC=CC1)NC(C(=O)NC(C(=O)CF)CC=2C=CC=CC2)CC=3C=CC=CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jonathan Frew, et al. Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency. Mol Neurodegener. 2020 Mar 16;15(1):21.?
molnova catalog
related products
-
2-cyano-Pyrimidine
2-cyano-Pyrimidine is inhibitor of cathepsin K(IC50 : 170 nM).
-
Cysteine protease in...
Cysteine protease inhibitor 2 is a cysteine protease inhibitor extracted from patent US20070032499A1, compound 12. Cysteine protease inhibitor 2 inhibited DCT116 and PC3 cells with GI50 values of 6.5 μM and 4.4 μM, respectively.
-
(1S,2R)-Alicapistat
(1S,2R)-Alicapistat ((1S,2R)-ABT-957) is a highly efficient, orally active compound that selectively inhibits human calpains 1 and 2, showing promise for Alzheimer's disease (AD) therapy .
